SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-033256
Filing Date
2023-11-30
Accepted
2023-11-30 16:29:37
Documents
13
Period of Report
2023-11-27
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ctdh20231129_8k.htm   iXBRL 8-K 37081
  Complete submission text file 0001437749-23-033256.txt   188292

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ctdh-20231127.xsd EX-101.SCH 3892
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ctdh-20231127_def.xml EX-101.DEF 13444
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctdh-20231127_lab.xml EX-101.LAB 17671
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctdh-20231127_pre.xml EX-101.PRE 13421
7 EXTRACTED XBRL INSTANCE DOCUMENT ctdh20231129_8k_htm.xml XML 4405
Mailing Address PO BOX 1180 ALACHUA FL 32616-1180
Business Address 6714 NW 16TH STREET, SUITE B GAINESVILLE FL 32653 386-418-8060
Cyclo Therapeutics, Inc. (Filer) CIK: 0000922247 (see all company filings)

IRS No.: 593029743 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39780 | Film No.: 231456199
SIC: 2836 Biological Products, (No Diagnostic Substances)